Generate a tailored SOP for Dr. David Ulmert. Improve your application with a focused, well-structured draft.
H. David Ulmert is an Associate Professor in the Department of Pharmacology at the University of California, Los Angeles. He received his M.D. from Lund University in 2006 and followed it with a Ph.D. in Clinical Chemistry from the same institution in 2007. His professional journey includes an internship in Surgery/Medicine at Helsingborg County Hospital, and a residency in Surgery at Skåne University Hospital. He further developed his expertise as a Research Fellow in Nuclear Medicine at Memorial Sloan Kettering Cancer Center and later became a Senior Research Scientist at the Sloan Kettering Institute. His research is focused on pioneering Positron-Emission Tomography (PET) RadioImmunoTherapy (RIT), which targets antigens in luminal tissues for cancer treatment. This innovative approach has led to collaborations with major pharmaceutical companies and the initiation of clinical studies. He has authored several significant publications on prostate-specific kallikreins as biomarkers for prostate cancer, contributing to impactful advancements in the field.
Memorial Sloan Kettering Cancer Center • New York, NY
Conducted research in Nuclear Medicine.
Sloan Kettering Institute • New York, NY
Focuses on pharmacology research and applications.
Department of Economics admits primarily for the PhD program.